https://www.slopeclinical.com https://www.slopeclinical.com/leadership https://www.slopeclinical.com/careers https://www.slopeclinical.com/contact https://www.slopeclinical.com/about https://www.slopeclinical.com/blog https://www.slopeclinical.com/request-demo https://www.slopeclinical.com/events https://www.slopeclinical.com/sign-up https://www.slopeclinical.com/terms-of-service https://www.slopeclinical.com/privacy-policy https://www.slopeclinical.com/in-the-news https://www.slopeclinical.com/ultimate-guide-to-managing-biological-samples-for-sites https://www.slopeclinical.com/ultimate-guide-to-managing-biological-samples-for-sponsors https://www.slopeclinical.com/resources https://www.slopeclinical.com/clinical-research-sites https://www.slopeclinical.com/dissecting-the-link-between-clinical-trial-monitoring-and-research-site-compliance https://www.slopeclinical.com/what-is-sample-tracking-and-why-is-it-important https://www.slopeclinical.com/mastering-sample-metadata-management-and-data-reconciliation-in-clinical-trials https://www.slopeclinical.com/software https://www.slopeclinical.com/services https://www.slopeclinical.com/iguides/requisition-workflows-reimagined/unlock https://www.slopeclinical.com/event/aaci-2025 https://www.slopeclinical.com/event/ctss-2025 https://www.slopeclinical.com/event/osss-2025 https://www.slopeclinical.com/event/scdm-emea-2025 https://www.slopeclinical.com/event/scope-2025 https://www.slopeclinical.com/event/scope-europe-2025 https://www.slopeclinical.com/event/the-future-of-requisition-forms https://www.slopeclinical.com/event/the-impact-of-ich-e6-r3-on-biospecimen-management https://www.slopeclinical.com/resources/10-ways-to-optimize-your-biospecimen-ops https://www.slopeclinical.com/resources/assess-the-roi-of-biospecimen360-tm-on-your-trial https://www.slopeclinical.com/resources/biospecimen360-product-brief https://www.slopeclinical.com/resources/biospecimen360-tm-your-key-to-ich-e6-r3-compliance https://www.slopeclinical.com/resources/de-risk-your-biospecimen-data-by-turning-your-static-lab-manuals-into-software-guided-workflows https://www.slopeclinical.com/resources/dissecting-the-link-between-clinical-trial-monitoring-and-research-site-compliance https://www.slopeclinical.com/resources/emerging-biotech-saved-over-300-000-on-phase-i-oncology-trial-with-slope https://www.slopeclinical.com/resources/ensuring-patient-centricity-in-oncology-trial-sample-management https://www.slopeclinical.com/resources/fierce-survey-report-infographic https://www.slopeclinical.com/resources/gabrail-cancer-center-streamlines-trials-and-cuts-inventory-waste-using-slope https://www.slopeclinical.com/resources/integrations-that-connect-everyone-everything https://www.slopeclinical.com/resources/mastering-sample-metadata-management-and-data-reconciliation-in-clinical-trials https://www.slopeclinical.com/resources/nci-designated-cancer-center-successfully-curtailed-inventory-chaos-using-slope https://www.slopeclinical.com/resources/note-to-file-podcast-research-sites-deep-dive-with-alex-yant-and-brad-hightower https://www.slopeclinical.com/resources/optimizing-your-clinical-trial-monitoring-strategy-to-boost-research-site-compliance https://www.slopeclinical.com/resources/requisition-workflows-reimagined https://www.slopeclinical.com/resources/sample-management-for-sponsors https://www.slopeclinical.com/resources/slope-for-iits https://www.slopeclinical.com/resources/slope-interviews-brad-hightower-on-note-to-file https://www.slopeclinical.com/resources/slope-makes-compliance-easy https://www.slopeclinical.com/resources/sponsor-brochure https://www.slopeclinical.com/resources/teal-healths-partnership-with-slope-contributes-to-fda-breakthrough-designation-for-groundbreaking-at-home-cervical-cancer-screening-device https://www.slopeclinical.com/resources/the-future-of-requisition-forms https://www.slopeclinical.com/resources/the-impact-of-ich-e6-r3-on-biospecimen-management https://www.slopeclinical.com/resources/the-slope-difference https://www.slopeclinical.com/resources/the-state-of-clinical-inventory-and-sample-management-for-clinical-trials https://www.slopeclinical.com/resources/the-value-of-turning-a-static-lab-manual-into-software-guided-workflows https://www.slopeclinical.com/resources/top-10-pharma-company-bypasses-central-lab-shaves-10-to-15-business-days-off-pk-biomarker-testing-turnaround-with-b360 https://www.slopeclinical.com/resources/uacc-reduced-scheduled-test-deviations-with-slope https://www.slopeclinical.com/resources/ultimate-guide-to-managing-biological-samples-for-sites-guide https://www.slopeclinical.com/resources/ultimate-guide-to-managing-biological-samples-for-sponsors-guide https://www.slopeclinical.com/resources/what-is-sample-tracking-and-why-is-it-important https://www.slopeclinical.com/blog/3-ways-to-fine-tune-your-clinical-trial-monitoring-strategy-to-minimize-protocol-deviations https://www.slopeclinical.com/blog/4-key-takeaways-from-dpharm-2023 https://www.slopeclinical.com/blog/4-questions-to-ask-when-developing-a-monitoring-strategy-for-a-complex-clinical-trial https://www.slopeclinical.com/blog/4-questions-to-ask-yourself-as-you-consider-clinical-trial-vendors https://www.slopeclinical.com/blog/4-reasons-that-research-sites-should-prioritize-how-theyre-managing-protocol-amendments https://www.slopeclinical.com/blog/4-reasons-you-should-consider-implementing-e-requisitions-on-your-clinical-trials https://www.slopeclinical.com/blog/4-ways-to-prevent-your-paper-e-requisition-forms-from-being-a-source-of-inefficiency https://www.slopeclinical.com/blog/5-tips-to-improve-your-research-sites-engagement-in-clinical-trial-monitoring https://www.slopeclinical.com/blog/a-conversation-with-slopes-new-coo-terry-edwards https://www.slopeclinical.com/blog/a-dmd-patient-and-clinical-trial-participant-shares-his-journey https://www.slopeclinical.com/blog/a-q-a-with-slopes-new-vp-of-product-brian-smith https://www.slopeclinical.com/blog/are-biomarkers-the-key-to-accelerated-approvals-for-rare-diseases https://www.slopeclinical.com/blog/are-boring-clinical-trials-better https://www.slopeclinical.com/blog/are-study-amendments-complicating-your-research-sites-sample-management-workflows-here-are-3-things-you-can-do-to-fix-it https://www.slopeclinical.com/blog/can-industry-outsiders-fix-clinical-research https://www.slopeclinical.com/blog/can-sample-management-processes-handle-the-new-tide-of-clinical-research-currently-no https://www.slopeclinical.com/blog/cancerx-announces-strategic-vision-and-inaugural-steering-committee https://www.slopeclinical.com/blog/clinical-operations-executives-weigh-in-on-study-start-up-challenges https://www.slopeclinical.com/blog/clinical-trial-monitoring-for-tissue-samples-is-your-sample-management-strategy-sufficient https://www.slopeclinical.com/blog/closing-the-gap-between-study-design-and-execution-the-need-for-better-sponsor-site-collaboration https://www.slopeclinical.com/blog/current-trends-in-biospecimen-management-that-are-hindering-your-trials https://www.slopeclinical.com/blog/does-it-seem-like-your-samples-disappear-into-a-black-hole-at-the-lab-here-are-4-reasons-why https://www.slopeclinical.com/blog/does-precision-medicine-live-up-to-the-hype https://www.slopeclinical.com/blog/embracing-a-holistic-approach-revolutionizing-clinical-research-tech-for-sites-and-sponsors https://www.slopeclinical.com/blog/ensuring-scientific-success-the-importance-of-monitoring-pre-analytical-variables-in-clinical-trials https://www.slopeclinical.com/blog/finding-your-north-star-why-patient-stories-are-the-bridge-between-clinical-trial-operations-the-human-experience https://www.slopeclinical.com/blog/forgetting-or-losing-samples-in-your-freezers-how-can-research-sites-optimize-their-sample-storage-solutions https://www.slopeclinical.com/blog/from-caregiver-to-patient-advocate-a-q-a-with-terri-ellsworth https://www.slopeclinical.com/blog/from-chaos-to-compliance-transforming-clinical-trial-monitoring-through-advanced-lab-kit-management https://www.slopeclinical.com/blog/from-cluttered-to-cutting-edge-how-better-lab-kit-organization-helped-a-research-site-open-a-phase-i-center https://www.slopeclinical.com/blog/from-paper-to-pixels-the-necessary-evolution-of-requisition-forms https://www.slopeclinical.com/blog/getting-to-the-root-cause-of-avoidable-protocol-deviations-and-violations https://www.slopeclinical.com/blog/having-trouble-tracking-down-that-critical-sample-heres-why https://www.slopeclinical.com/blog/highlights-from-our-insightful-roundtable-discussion-on-sample-reconciliation https://www.slopeclinical.com/blog/how-can-a-clinical-trial-execution-platform-support-your-monitoring-strategy-for-protocol-amendments https://www.slopeclinical.com/blog/how-can-clinical-research-sites-supplement-the-training-they-receive-on-their-studies https://www.slopeclinical.com/blog/how-can-clinical-trial-data-integration-streamline-biospecimen-data-entry-and-reconciliation https://www.slopeclinical.com/blog/how-can-my-research-site-prevent-sample-mishandling https://www.slopeclinical.com/blog/how-can-research-sites-address-challenges-with-managing-protocol-amendments-on-their-clinical-trials https://www.slopeclinical.com/blog/how-can-sponsors-determine-their-ich-e6-r3-risk-profile-for-biospecimens https://www.slopeclinical.com/blog/how-can-you-unlock-the-power-of-biospecimen-data-for-translational-medicine https://www.slopeclinical.com/blog/how-can-your-biospecimen-operations-impact-your-database-locks https://www.slopeclinical.com/blog/how-do-complex-clinical-trials-contribute-to-research-site-compliance-issues https://www.slopeclinical.com/blog/how-do-protocol-amendments-factor-into-your-clinical-trial-monitoring-plan https://www.slopeclinical.com/blog/how-does-execution-of-the-lab-manual-at-research-sites-impact-sponsors https://www.slopeclinical.com/blog/how-to-reduce-edc-queries-at-your-research-site https://www.slopeclinical.com/blog/how-to-stand-out-from-other-research-sites-a-recap-of-slopes-panel-discussion-with-other-industry-leaders-at-global-site-solutions-summit https://www.slopeclinical.com/blog/ich-e6-r3-impacts-your-biospecimen-operations-why-sponsors-must-act-now https://www.slopeclinical.com/blog/ich-e6-r3-raises-the-bar-for-data-governance----and-biospecimen-management-is-no-exception https://www.slopeclinical.com/blog/integrating-edc-and-sample-management-solutions https://www.slopeclinical.com/blog/is-your-approach-to-handling-lab-data-hurting-your-trials https://www.slopeclinical.com/blog/is-your-approach-to-sample-risk-management-leaving-your-biospecimens-vulnerable-heres-how-to-fix-it https://www.slopeclinical.com/blog/is-your-strategy-for-managing-lab-to-lab-sample-shipments-jeopardizing-your-trial https://www.slopeclinical.com/blog/is-your-study-on-track-for-the-next-dose-escalation-ask-yourself-these-4-questions https://www.slopeclinical.com/blog/key-takeaways-from-our-site-led-sample-management-roundtable https://www.slopeclinical.com/blog/lab-kit-management-what-can-research-sites-learn-from-other-industries https://www.slopeclinical.com/blog/lab-kits-the-blueprint-for-sample-tracking-success https://www.slopeclinical.com/blog/lasting-progress-in-lab-kit-management-a-follow-up-conversation-with-upmc-hillman-cancer-center https://www.slopeclinical.com/blog/less-inventory-waste-more-time-a-poster-presentation-with-upmc-hillman-cancer-center https://www.slopeclinical.com/blog/looking-ahead-to-2024-fostering-connection-and-empathy-to-solve-big-problems https://www.slopeclinical.com/blog/oh-no-my-research-site-experienced-a-protocol-deviation-and-it-was-our-mistake-what-now https://www.slopeclinical.com/blog/q-a-with-edye-edens https://www.slopeclinical.com/blog/q-a-with-slope-a-celebration-of-clinical-research https://www.slopeclinical.com/blog/q-a-with-slope-meet-carlos-pigotti-site-development-consultant https://www.slopeclinical.com/blog/q-a-with-slope-meet-gabrielle-jones-our-newest-site-development-consultant https://www.slopeclinical.com/blog/q-a-with-slope-meet-ross-cooper-slopes-resident-expert-on-iits https://www.slopeclinical.com/blog/research-site-best-practices-for-collaborating-with-cras-on-clinical-trial-monitoring https://www.slopeclinical.com/blog/selecting-vendors-systems-that-enhance-clinical-trial-monitoring https://www.slopeclinical.com/blog/slope-at-scope-2024-bridging-the-biospecimen-data-gap https://www.slopeclinical.com/blog/slope-raises-20m-in-series-a-funding-to-revolutionize-clinical-trial-operations-through-automation https://www.slopeclinical.com/blog/sponsors-your-oversight-responsibilities-have-changed-the-new-compliance-risks-in-biospecimen-management https://www.slopeclinical.com/blog/sprint-to-success-how-speed-and-agility-in-biospecimen-operations-empower-sponsors-to-accelerate-clinical-research https://www.slopeclinical.com/blog/the-chaos-of-clinical-research-coordination-drowning-in-lab-kits https://www.slopeclinical.com/blog/the-impact-of-poor-sample-management https://www.slopeclinical.com/blog/the-importance-of-empowering-clinical-research-sites-understanding-the-synergy-between-sample-management-and-inventory-management-in-clinical-trials https://www.slopeclinical.com/blog/the-importance-of-including-inventory-sample-lifecycle-management-in-your-clinical-trial-monitoring-plan https://www.slopeclinical.com/blog/the-most-common-reasons-for-testing-cancellations-and-how-to-prevent-them https://www.slopeclinical.com/blog/the-most-prevalent-challenges-around-biospecimen-data-operations-a-q-a-with-mandy-schreiber https://www.slopeclinical.com/blog/the-people-of-slope-have-spoken-were-a-great-place-to-work https://www.slopeclinical.com/blog/the-rising-disparity-between-legal-medical-and-clinical-trial-sample-chain-of-custody https://www.slopeclinical.com/blog/the-tip-of-the-iceberg-looking-below-the-surface-to-track-samples-at-the-site https://www.slopeclinical.com/blog/the-top-3-reasons-your-central-labs-e-requisition-forms-fall-short https://www.slopeclinical.com/blog/the-top-5-complex-trial-types-that-rely-on-sample-management https://www.slopeclinical.com/blog/the-top-5-questions-to-ask-your-trial-partners-about-sample-management https://www.slopeclinical.com/blog/the-top-5-sample-management-issues-that-could-prevent-early-phase-dose-escalation https://www.slopeclinical.com/blog/the-vicious-cycle-of-clinical-inventory-management https://www.slopeclinical.com/blog/tired-of-being-bogged-down-by-lab-queries-heres-whats-causing-them-and-what-you-can-do-to-reduce-the-burden https://www.slopeclinical.com/blog/understanding-clinical-research-site-challenges-with-biospecimen-data-entry-and-reconciliation https://www.slopeclinical.com/blog/unmasking-the-centricity-illusion-in-clinical-trials https://www.slopeclinical.com/blog/using-edc-and-paper-requisition-forms-to-capture-data-for-sample-tracking-heres-why-thats-not-effective https://www.slopeclinical.com/blog/utilizing-a-central-lab-vs-shipping-directly-to-speciality-labs-important-considerations-for-your-next-trial https://www.slopeclinical.com/blog/what-21-cfr-part-11-taught-us-about-partial-compliance----and-why-the-same-lessons-apply-to-ich-e6-r3-today https://www.slopeclinical.com/blog/what-can-aristotle-teach-us-about-the-importance-of-research-site-compliance-to-successful-clinical-trial-outcomes https://www.slopeclinical.com/blog/what-can-research-sites-do-to-better-manage-multiple-clinical-trial-vendors-systems https://www.slopeclinical.com/blog/what-can-research-sites-do-to-standardize-their-processes-for-more-efficient-compliant-trials https://www.slopeclinical.com/blog/what-can-the-game-of-telephone-tell-us-about-our-current-approaches-to-sample-management https://www.slopeclinical.com/blog/what-do-ich-e6-r3-s-heightened-risk-based-quality-standards-mean-for-biospecimen-management https://www.slopeclinical.com/blog/what-does-clinical-trial-monitoring-have-to-do-with-lab-kit-management-and-sustainability https://www.slopeclinical.com/blog/what-happens-when-sites-dont-have-real-time-visibility-to-clinical-inventory https://www.slopeclinical.com/blog/what-is-research-site-standardization-and-what-does-it-have-to-do-with-your-clinical-trials-centralized-monitoring-plan https://www.slopeclinical.com/blog/what-is-sample-management https://www.slopeclinical.com/blog/what-is-sample-metadata-in-clinical-trials-all-your-questions-answered https://www.slopeclinical.com/blog/what-the-biospecimen-management-world-can-learn-from-edc-and-epro https://www.slopeclinical.com/blog/why-is-it-so-hard-to-track-sample-shipments-from-research-site-to-lab https://www.slopeclinical.com/blog/why-sponsors-need-expertise-in-biospecimen-lifecycle-management-to-bring-their-breakthroughs-to-life https://www.slopeclinical.com/blog/working-effectively-with-biospecimen-labs-a-conversation-with-amy-blyskal